Export

EN
FR
Sodium stibogluconate
Essential medicine status
General description
Sodium stibogluconate is a antimony derivative used to treat visceral, cutnaeous and mucosal leishmaniasis.
INN
Sodium stibogluconate
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Visceral leishmaniasis
Changed in 1977 (TRS 615) for Cutaneous leishmaniasis
Removed in 1989 (TRS 796) for Visceral leishmaniasis
Changed in 1989 (TRS 796) for Cutaneous leishmaniasis
Added in 2007 (TRS 950) for Visceral leishmaniasis
Changed in 2007 (TRS 950) for Cutaneous leishmaniasis
Therapeutic equivalent for
Recommendations
Section
Antileishmaniasis medicines
  • Parenteral > General injections > unspecified: 100 mg per mL in 30 mL vial